Anticoagulation Forum

Education & CE

VTE Prophylaxis in Acutely Ill Medical Patients

Patients who are hospitalized for acute medical illness, such as heart failure, respiratory insufficiency, stroke, and infectious or inflammatory diseases, are at increased risk for venous thromboembolism (VTE). This presentation highlights available evidence, providing risk assessment options, pharmacological dosing options, and consideration for extended duration thromboprophylaxis, as outlined in the AC Forum Rapid Resource: “VTE Prophylaxis in Acutely Ill Medical Patients”.

Faculty:
Scott Kaatz, DO, MSc
Ronni Nemeth, PharmD, CACP, DPLA
Allison Burnett, PharmD, CACP, PhC
Steve Deitelzweig, MD, MMM

Boot Camp Fundamentals

This program features two modules originally presented as part of our AC Forum Virtual Boot Camp curriculum in 2021. These 45-minute video presentations will give you a thorough background prior to attending AC Forum Boot Camp or before completing other more complex coursework. Pharmacists can claim up to 1.5 hours of enduring CE after completing these modules and filling out the course evaluation found here: http://www.acf.cmecertificateonline.com/

Module 1: Hemostasis & Thrombosis Fundamentals
Dan Witt, PharmD, University of Utah College of Pharmacy

Module 2: Clinical Application of Anticoagulant Drug Pharmacology
Sara R. Vazquez, PharmD, BCPS, CACP, University of Utah Health Thrombosis Service

Continuing Education

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Anticoagulation Forum. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacists and Pharmacy Technicians (ACPE)
Amedco LLC designates this activity for a maximum of 1.5 knowledge-based CPE contact hours.

Target Audience: This activity has been designed to meet the educational needs of physicians, pharmacists, registered nurses and associated health professionals who work in the field of anticoagulation.

Compact Lessons

	Cancer-Associated Thrombosis Video David Garcia, MD This short whiteboard video outlines important considerations for patients with cancer and their risk of blood clots. Dr. David Garcia provides patients with information about the signs, symptoms, and treatment for cancer-associated thrombosis. This project was supported through a grant from the BMS-Pfizer Alliance.

	Vascular Protection Animated Lesson Jeff Weitz, MD, FRCP(C), FACP This short and concise animated video addresses the history of cardiovascular disease, the role of anticoagulation in vascular protection and an overview of the methods of treatment for thrombosis.

	Efficiency and Effectiveness of Anticoagulation – Related Discharge Communication Kelly Rudd, PharmD, FCCP, BCPS, CACP Dr. Rudd reviews her poster evaluating the effectiveness and efficiency of an anticoagulation discharge summary using 14 elements considered essential during care transitions (IPRO's Anticoagulation Discharge Communication tool). Results will help to inform improvements in future tools. Originally presented at THSNA 2018.

	Structure and Function of US Anticoagulation Clinics: An AC Forum Membership Survey Geoffrey Barnes, MD, MSc Dr. Barnes provides an overview of survey results from member clinics about their structure, function and services in his presentation from THSNA 2018. Thank you to our members for participating in this important survey. Read more detailed results in the Journal of Thrombosis and Thrombolysis.